March 2022 Anthem Blue Cross Provider News - California

Contents

AdministrativeCommercialMarch 1, 2022

Timely access regulations and language assistance program

AdministrativeCommercialMarch 1, 2022

Understanding your patients’ differences is lifesaving

AdministrativeCommercialMarch 1, 2022

Simplifying requests for additional information

AdministrativeCommercialMarch 1, 2022

New! Vaccination resource page for providers

Medical Policy & Clinical GuidelinesCommercialMarch 1, 2022

Updated preventive care guidance regarding screening colonoscopies

State & FederalMedicaidMarch 1, 2022

It is CAHPs survey time!

State & FederalMarch 1, 2022

Keep up with Cal MediConnect news - March 2022

State & FederalMedicare AdvantageMarch 1, 2022

Keep up with Medicare news – March 2022

State & FederalMedicare AdvantageMarch 1, 2022

New Strategic Provider System will launch in April 2022

State & FederalMedicare AdvantageMarch 1, 2022

Teamsters Retiree Trust offers Medicare Advantage option

State & FederalMedicare AdvantageMarch 1, 2022

Clinical criteria updates

State & FederalMedicare AdvantageMarch 1, 2022

Pharmacy updates

State & FederalMedicare AdvantageMarch 1, 2022

Annual wellness visits for Medicare Advantage members

State & FederalMedicaidMarch 1, 2022

Keep up with Medi-Cal news – March 2022

State & FederalMedicaidMarch 1, 2022

Urinary tract infection toolkits are on the way

State & FederalMedicaidMarch 1, 2022

Clinical utilization management guidelines update

AdministrativeCommercialMarch 1, 2022

CAA: Have you reviewed your online provider directory information lately?

We are asking you to review your online provider directory information on a regular basis to ensure it is correct. Access your information by visiting anthem.com/ca, select Providers, then under Provider Overview, choose Find Care.

 

Submit updates and corrections to your directory information using our online Provider Maintenance Form. Online update options include:

  • add/change an address location
  • name change
  • tax ID changes
  • provider leaving a group or a single location
  • phone/fax number changes
  • closing a practice location

 

Once you submit the form, we will send you an email acknowledging receipt of your request.

 

The Consolidated Appropriations Act (CAA) contains a provision that requires online provider directory information be reviewed and updated (if needed) at least every 90 days. By reviewing your information regularly, you can help us ensure your online provider directory information is current.

799-0322-PN-CA

AdministrativeCommercialMarch 1, 2022

Timely access regulations and language assistance program

News for 2022

  • The 2021 Provider Appointment Availability Surveys (PAAS) have recently concluded.
  • Each year we communicate Anthem’s Timely Access Regulations and Language Assistance Program to our commercial Medical and Behavioral Health networks via an annual provider mailing.  The 2022 mailing was completed in February.
  • SB 221, effective July 1, 2022 – Timely Access Requirements for Non-Physician Mental Health/Substance Use Disorder Appointments.  More details follow the Access Standards for Medical Professionals table below.

 

Please take a moment to review and share with your staff the Access Standards tables for Medical Professionals and Behavioral Health that follow.

Type of Care

Standard

Non-urgent appointments for Primary Care (PCP)

Must offer the appointment within 10 business days of the request

Urgent Care appointments not requiring prior authorization

Must offer the appointment within 48 hours of request

Non-urgent appointments with Specialist Physicians

Must offer the appointment within 15 business days of the request

Urgent Care (that requires prior authorization)

Must offer the appointment within 96 hours of request

Non-urgent appointment for ancillary services (for diagnosis or treatment of injury, illness, or other health condition)

Must offer the appointment within 15 business days of the request

After Hours Care

Member to reach a recorded message or live voice response providing emergency instructions; and for non-emergent (urgent) matters, information when to expect to receive a call back

Emergency Care:  Anthem Blue Cross expects every practitioner to instruct their after-hours answering service staff that if the caller is experiencing an emergency, the caller should be instructed to dial 911 or to go directly to the emergency room.  Answering machine instructions must also direct the member to call 911 or go to the emergency room if the caller is experiencing an emergency.

Immediate Access to Emergency Care.

Members are directed to dial 911 or go to the nearest emergency room

Member Services by Telephone:  Access to Member Services to obtain information about how to access clinical care and how to resolve problems.  (This is a Plan responsibility and not a physician responsibility; and this also applies to our Behavioral Health members.)

Reach a live person within 10 minutes during normal business hours (Plan standard: 45 seconds; Call abandonment rate <5%). The Member NurseLine is available 24/7 and the wait time is not to exceed 30 minutes.

 

Access Standards for Medical Professionals

 

Note: The next available appointment date and time can be either In-Person or by Telehealth.

For questions, please visit the Contact Us page on our provider website for up-to-date contact information. You can also email the Provider Experience team directly using the electronic form.

 

Changes are coming!  Effective July 1, 2022 – Timely Access Requirements for Non-Physician Mental Health/Substance Use Disorder Appointments

 

On October 8, 2021, the State Senate passed SB 221. This bill requires health care service and Managed Care Plans that fall under the jurisdiction of Department of Managed Health Care and the Department of Insurance, to ensure that appointments with Non-Physician Mental Health and Substance Use Disorder providers are subject to the Timely Access Requirements, as specified on the charts below, beginning July 1, 2022.  This bill also requires that all health plans ensure that enrollees who are undergoing a course of treatment for an ongoing Mental Health or Substance Use Disorder condition can schedule a follow up appointment with their Non-physicians Mental Health Care or Substance use Disorder provider within 10 business days of the prior appointment.

 

We hope this clarifies Anthem’s expectations and your obligations regarding compliance with the Timely Access Regulations. Our goal is to work with you to successfully meet the expectations for the requirements with the least amount of difficulty and member abrasion.

 

Access Standards for Behavioral Health and EAP Providers

Type of Care

Standard

Emergency Care Instructions

(Anthem Blue Cross expects every practitioner to instruct their after-hours answering service staff that if the caller is experiencing an emergency, the caller should be instructed to dial 911 or to go directly to the emergency room. Answering machine instructions must also direct the member to call 911 or go the emergency room if the caller is experiencing an emergency) Members are directed to 911 or the nearest emergency room.

 

Members are directed to 911 or the nearest emergency room.

 Non-Life-Threatening Emergency Care

Appointment within 6 hours

Members are directed to 911 or the nearest emergency room.

Urgent Care (does not require prior authorization)

Appointment within 48 hours

Members are directed to 911 or the nearest emergency room.

Urgent Care (requires prior authorization)

Appointment within 96 hours

Members are directed to 911 or the nearest emergency room.

Routine Office Visit/Non-urgent Appointment

10 business days (Psychiatrists)*

10 business days (Non-Physician Mental Health Care

     Providers)

5 business days (EAP)

Access to After-hours Care

Available 24 hours/7 days. Member to reach a recorded message or live voice response providing emergency care instructions, and for non-emergent (urgent) matters, a mechanism to reach a Behavioral Health/EAP provider and
be informed when the call will be returned.

 

* The DMHC Timely Access standard is 15 Business days for Psychiatrists; however, to comply with the NCQA accreditation standard of 10 Business Days, Anthem uses the more stringent standard.

Note:  The next available appointment date and time can be either In-Person or by Telehealth services.

 

For questions, please visit the Contact Us page on our provider website for up-to-date contact information. You can also email the Provider Experience team directly using the electronic form.

Why is this important?  These are California state regulations.

Blue Cross of California dba Anthem Blue Cross and Anthem Blue Cross Life & Health Insurance Company (collectively, Anthem”) are committed to keeping you, our network partners, updated on our activities related to our compliance with the Department of Managed Health Care (DMHC) and the California Department of Insurance (CDI) Timely Access to Non-Emergency Health Care Services Regulations (the “Timely Access Regulations”), respectively.

 

To ensure compliance with these Timely Access Regulations, three (3) surveys are conducted annually; and the 2021 surveys have recently concluded.  These activities include, but are not limited to the following:

 

  • Provider Appointment Availability Survey
  • Provider Satisfaction Survey
  • Provider After – Hours Survey

 

Each year we communicate Anthem’s Timely Access Regulations and Language Assistance Program to our commercial Medical and Behavioral Health networks.  The 2022 notice was mailed in February.  This information also includes access to non-emergency health care services within prescribed timeframes (also referred to as the “time elapsed standards” or “appointment wait times”). We appreciate that in certain circumstances time-elapsed requirements may not be met. The Timely Access Regulations have provided exceptions to the time-elapsed standards to address these situations:

 

Extending Appointment Wait Time: The applicable waiting time for a particular appointment may be extended if the referring or treating licensed health care provider, or the health professional providing triage or screening services, as applicable, acting within the scope of his or her practice and consistent with professionally recognized standards of practice, has determined and noted in the relevant record that a longer waiting time will not have a detrimental impact on the health of the patient.

Preventive Care Services and Periodic Follow-up Care: Preventive care services and periodic follow up care are not subject to the appointment availability standards. These services may be scheduled in advance consistent with professionally recognized standards of practice as determined by the treating licensed health care provider acting within the scope of his or her practice. Periodic follow-up care includes but is not limited to, standing referrals to specialists for chronic conditions, periodic office visits to monitor and treat pregnancy, cardiac or mental health conditions, and laboratory and radiological monitoring for recurrence of disease.

Advanced Access: The primary care appointment availability standard may be met if the primary care physician office provides “advanced access.” “Advanced access” means offering an appointment to a patient with a primary care physician (or nurse practitioner or physician’s assistant) within the same or next business day from the time an appointment is requested (or a later date if the patient prefers not to accept the appointment offered within the same or next business day). Note: This exception does not apply to commercial Behavioral Health.

24/7 NurseLine Gives Peace of Mind

Anthem members have access to our 24/7 NurseLine. A convenient way to ask questions or get advice from a registered nurse anytime. Locate the toll-free phone number on the back of the Member ID card and the wait time is not to exceed 30 minutes.  

Help is a Phone Call Away

Members and Providers have access to Anthem’s Member Services team for general questions or when having difficulty obtaining a referral to a provider. Call the toll-free phone number listed on the back of the member ID card for assistance. A representative may be reached within 10 minutes during normal business hours.

 

For Patients (Members) with DMHC Regulated Health Plans

If you or your patients are unable to obtain a timely referral to an appropriate provider or for more information about the regulations, visit the DMHC website at www.dmhc.ca.gov or call toll-free 1-888-466-2219 for assistance.

 

For Patients (Members) with CDI Regulated Health Plans

If you or your patients are unable to obtain a timely referral to an appropriate provider or for more information about the regulations, visit the CDI website at www.insurance.ca.gov or call toll-free 1-800-927-4357 for assistance.

 

Language Assistance Program

For members whose primary language is not English, Anthem offers, at no cost, language assistance services through interpreters and other written languages. If you or the member is interested in these services, please call the Anthem Member Services number on the member’s ID card for help (TTY/TDD: 711).

 

We hope this clarifies Anthem’s expectations and your obligations regarding compliance with the Timely Access Regulations. Our goal is to work with you, to successfully meet the expectations for the requirements with the least amount of difficulty and member abrasion. Anthem can only achieve this compliance with the help of our network providers, you! 

791-0322-PN-CA

AdministrativeCommercialMarch 1, 2022

Understanding your patients’ differences is lifesaving

Colorectal cancer is the most common cause of cancer death among Asian Americans1, while African Americans are 40% more likely to die from the disease than any other racial or ethnic group2 in the United States. There are many possible reasons for the differences in survival rates among these racial and ethnic groups, but the common thread between them both is screening. For African Americans and Asian Americans, the reluctance could be cultural. They may not be as likely to ask about the screenings as their White counterparts.

 

Resources to help talk to patients about colorectal cancer screening

The Centers for Disease Control and Prevention website is an excellent resource for information about colorectal cancer that you can share with your patients. There is even a quiz to help your patients understand the importance of screening as a prevention.

 

We’ve also developed two videos for you to play in your patient waiting room, share with patients in the exam room, or share the link through your digital schedulers.

 

Colorectal Screening for Asian Americans
Colorectal cancer screening for African Americans

 

Measure up: HEDIS ® measures members ages 50–75 who receive the appropriate screening for colorectal cancer.

There are multiple test types that meet the requirement:

  • Screening colonoscopy every 10 years
  • Screening flexible sigmoidoscopy every 5 years
  • Computed tomography (CT) colonography every 5 years
  • Screening fecal occult blood test (FOBT) annually
  • FIT DNA (i.e., Cologuard®) at home testing every 3 years

 

Coding Tips

For screening, use the appropriate code:

 

Screening

Commonly used billing codes

Flexible sigmoidoscopy

CPT: 45330–45335, 45337–45342, 45346, 45347, 45349, 45350

HCPC: G0104

FIT-DNA (i.e., Cologuard®)

CPT: 81528

Occult blood test
(FOBT, FIT, guaiac)

CPT: 82270, 82274

HCPC: G0328

Colonoscopy

CPT: 44388–44394, 44401–44408, 45378–45386, 45398, 45388–45693

HCPC: G0105, G0121

CT Colonography

CPT: 74261, 74262

 

For exclusions, use the appropriate ICD-10 code:

 

ICD-10

Description

Z85.038

Personal history of other malignant neoplasm of large intestine

Z85.048

Personal history of other malignant neoplasm of rectum, rectosigmoid junction and anus

Z51.5

Encounter palliative care

 

HEDIS® is a registered trademark of the National Committee for Quality Assurance (NCQA)

 

1 “Colorectal cancer in the United States and a review of its heterogeneity among Asian American subgroups”, https://onlinelibrary.wiley.com/doi/full/10.1111/ajco.13324#:~:text=Colorectal%20cancer%20is%20the%20second,common%20in%20the%20%20United%20States

 

2 “Colorectal Cancer Rates Higher in African Americans, Rising in Younger People”, https://www.cancer.org/latest-news/ectal-cancer-rates-higher-in-african-americans-rising-in-younger-people.html
820-0322-PN-CA

AdministrativeCommercialMarch 1, 2022

Your influence matters: Recommending cancer screenings to your patients

Patients say they more likely to have a cancer screening when their physician recommends it. What else can you do to influence cancer screenings?1

  • Understand the power of the physician recommendation.
    • Your recommendation is the most influential factor in whether a person decides to get screened.
    • Patients are 90% more likely to get a screening when they reported a physician recommendation.
    • “My doctor did not recommend it,” is the primary reason for screening avoidance.
  • Recognize cultural barriers that may impact your diverse patients
  • Culturally sensitive conversations with your patients can help with fear, embarrassment, anxiety, and misconceptions about screenings.
  • Go to mydiversepatients.com for information and resources.
  • Measure the screening rates in your practice; it may not be as high as you think.
    • Set goals to get screening rates up.
    • Follow the HEDIS® guidelines included in this article to help accurately track your care gap closures.
  • More screening doesn’t have to mean more work for you.
    • Reach out to us about available member data – we may be able to help identify or supply access to data for those members who are due screenings.
    • Develop a reminder system, which has been demonstrated to be effective, to remind you and staff that patients have screenings due.
  • Help members access benefit information about screenings to eliminate the cost barrier.
    • Log onto Availity.com and use the Patient Information tab to run an Eligibility and Benefits inquiry.
    • Members can access their benefit information by logging onto Anthem.com, through Live Chat, or by downloading the Sydney Health App.
    • Blue Cross Blue Shield Service Benefit Plan members, also known as Federal Employee Program® members, can access their benefit information by logging onto fepblue.org, or by downloading the fepblue App from the Apple Store or on Google Play.

 

Measure Up: Cancer Screening for Women HEDIS® Measure Specifications

Organized and continuous screenings along with removal of precancerous lesions can lead to a 60% decrease in cervical cancer.2

 

Cervical Cancer Screening (CCS) is measured by the percentage of women 21 to 64 years of age who were screened for cervical cancer using either of the following criteria:

  • Women 21–64 years of age who had cervical cytology performed within the last 3 years.
  • Women 30–64 years of age who had cervical high-risk human papillomavirus (hrHPV) testing performed within the last 5 years.
  • Women 30–64 years of age who had cervical cytology/high-risk human papillomavirus (hrHPV) co-testing within the last 5 years.

Description

Code

Cervical cytology lab test

CPT: 88141–88143, 88147, 88148, 88150, 88152–88153, 88164–88167, 88174, 88175

HCPCS: G0123, G0124, G0141, G0143-G0145, G0147, G0148, P3000, P3001, Q0091

LOINC: 10524-7, 18500-9, 19762-4, 19764-0, 19765-7, 19766-5, 19774-9, 33717-0, 47527-7, 47528-5

hrHPV lab test

CPT: 87620–87622, 87624–87625

HCPCS: G0476

LOINC: 21440-3, 30167-1, 38372-9, 59263-4, 59264-2, 59420-0, 69002-4, 71431-1, 75694-0, 77379-6, 77399-4, 77400-0, 82354-2, 82456-5, 82675-0

Absence of cervix diagnosis

ICD-10-CM: Q51.5, Z90.710, Z90.712

Hysterectomy with no residual cervix

CPT: 51925, 56308, 57530, 57531, 57540, 57545, 57550, 57555, 57556, 58150, 58152, 58200, 58210, 58240, 58260, 58262, 58263, 58267, 58270, 58275, 58280, 58285, 58290, 58291, 58292, 58293, 58294, 58548, 58550, 58552, 58553, 58554, 58570, 58571, 58572, 58573, 58575, 58951, 58953, 58954, 58956, 59135

ICD-10-PCS: 0UTC0ZZ, 0UTC4ZZ, 0UTC7ZZ, 0UTC8ZZ


HEDIS® is a registered trademark of the National Committee for Quality Assurance (NCQA).

 

1 http://thecanceryoucanprevent.org/wp-content/uploads/14893-80_2018-PROVIDER-PHYS-4-PAGER-11-10.pdf

2 National Library of Medicine. https://pubmed.ncbi.nlm.nih.gov/9253676/

819-0322-PN-CA

AdministrativeCommercialMarch 1, 2022

Simplifying requests for additional information

In the months ahead, you will notice that our correspondence to you has changed. We’ve simplified our requests for additional information by providing exactly the information you need to know, enabling quicker claims processing and faster payments.

 

Enabling digital responses
Our new correspondence format includes the easiest, fastest, and most efficient way to return the information requested. We’ll provide you with instructions about how to submit the information digitally. Whether it is through the Claims & Payments application for resubmission or by using the Attachments application, it is all in one place and accessible by logging onto Availity.com.

 

Digital responses to our request for additional information is one of the ways we can work together to reduce the amount of time and expense associated with claims processing.

Become an Availity user today

If you aren’t registered to use Availity, signing up is easy and 100% secure. There is no cost for our providers to register or to use any of the digital applications including our correspondence to you. Start by logging onto Availity.com and selecting the Register icon at the top of the home screen or use this link to access the registration page.

816-0322-PN-CA

AdministrativeCommercialMarch 1, 2022

Coastal Foundation no longer provides claims and customer service for SISC

As a reminder, effective January 1, 2022, the Coastal Foundation located in Salinas, California, which provided claims and customer service for Self-Insured Schools of California (SISC) members no longer support those members. Please be sure to verify each member’s ID card to obtain the most up to date customer service phone number and mailing address. Up to date information can also be found in the Availity portal. SISC members can be identified by alpha prefix “SIF” on their member ID card.

AdministrativeCommercialMarch 1, 2022

New! Vaccination resource page for providers

Consumer surveys show that doctors are the most persuasive and influential source of information around vaccines. Anthem Blue Cross (Anthem) is working to make it easier for physicians to offer their strong recommendations for vaccinations – especially vaccines for COVID-19 and influenza.

 

Anthem recently launched a single page to host resources for health care professionals related to vaccination, including a guide to talking with reluctant patients to respond to common concerns, and one comparing flu and COVID-19 vaccines.

 

We will continue to refresh and add to available content on the new vaccination resource page.  

 

Visit our website for the most up to date COVID-19 information from Anthem.

776-0322-PN-CA 

Digital SolutionsCommercialMarch 1, 2022

Enhancements to the Availity Authorization application are now available

We appreciate the feedback you shared about the Availity multi-payer Authorization application. Thanks to the insight about your user experience, we’ve made enhancements that we hope will improve your experience even more.

Submissions through Interactive Care Reviewer (ICR)
We appreciate the input you provided about the landing page to the ICR application. The landing page was designed to make it easier to navigate to ICR, but we heard it was confusing. We have made a correction to the landing page making it easier to understand and to navigate to ICR for:

 

  • Behavioral health member authorizations and inquiries
  • Appeals
  • Federal Employee Program member submissions
  • Medical specialty pharmacy authorizations and inquiries.

 

Tip: As a reminder, you will receive an error message if you submit an authorization through Availity when it should have been submitted through ICR. This is another way to ensure your authorizations are being processed accurately. If an authorization is submitted through Availity and it should have been submitted through ICR, it will not process correctly and could cause delays in patient care.

 

Authorization Reference Number Latency
The amount of time it took to receive your authorization reference number was prolonged during the initial launch period. While it may have taken a few extra minutes, this did not prevent you from continuing to submit additional authorizations while waiting for an authorization reference number. Access your authorization reference number at any time from your dashboard. You can also sort, filter and check the status of your authorizations from your dashboard.

 

Continue to share your experience

We are updating and making enhancements to the Anthem experience in the Availity multi-payer Authorization application based on your input and feedback. If you are experiencing an issue using the application, reach out to Availity Client Services at 1-800-282-4548. Screen shots, case information, dates of service are all helpful pieces of information to assist the service team in identifying and correcting the issues.



Become an Availity user today

If you aren’t registered to use Availity, signing up is easy and 100% secure. There is no cost for our providers to register or to use any of the digital applications. Start by logging onto Availity.com and selecting the Register icon at the top of the home screen or use this link to access the registration page.



818-0322-PN-CA

Medical Policy & Clinical GuidelinesCommercialMarch 1, 2022

Updated preventive care guidance regarding screening colonoscopies

On January 10, 2022, updated Preventive Care Guidance was released by the Departments of Labor, Health and Human Services (HHS), and the Treasury. This new guidance applies to most of Anthem Blue Cross’ (Anthem) ACA-complaint non-grandfathered health plans when services are provided in-network. This new guidance indicates:

 

On May 18, 2021, the USPSTF updated its recommendation for colorectal cancer screening The USPSTF continues to recommend with an “A” rating screening for colorectal cancer in all adults aged 50 to 75 years and extended its recommendation with a “B” rating to adults aged 45 to 49 years. In its “Practice Considerations” section detailing screening strategies, the Final Recommendation Statement provides: “When stool-based tests reveal abnormal results, follow-up with colonoscopy is needed for further evaluation…. Positive results on stool-based screening tests require follow-up with colonoscopy for the screening benefits to be achieved.” Additionally, the Final Recommendation Statement provides with respect to direct visualization tests: “Abnormal findings identified by flexible sigmoidoscopy or CT colonography screening require follow-up colonoscopy for screening benefits to be achieved.”

 

For a follow-up colonoscopy after a positive non-invasive stool-based screening test or direct visualization screening test for colorectal cancer, in-network providers should code the claim as a screening colonoscopy rather than as a diagnostic colonoscopy.

 

Providers can contact the provider service number on the back of the member ID card to determine if a member’s plan includes this benefit.

807-0322-PN-CA

CalPERSCommercialMarch 1, 2022

Benefit change for CalPERS PPO Members: Important updates on certain medications‐ bevacizumab (Avastin), epoetin alfa (Epogen and Procrit), filgrastim (Neupogen), pegfilgrastim (Neulasta), rituximab (Rituxan), and trastuzumab (Herceptin)

As a reminder, effective January 1, 2022, the CalPERS PERS Platinum and PERS Gold PPO Basic Plans were redesigned to utilize biosimilar agents including but not limited to the following:

 

  • Mvasi, Zirabev instead of Avastin (bevacizumab) EXCLUDES Ophthalmologic indications
  • Retacrit instead of Epogen and Procrit (epoetin alfa)
  • Nivestym, Zarxio instead of Neupogen (filgrastim)
  • Fulphila, Nyvepria, Udenyca, Ziextenzo instead of Neulasta (pegfilgrastim)
  • Riabni, Ruxience, Truxima, instead of Rituxan (rituximab)
  • Herzuma, Kanjinti, Ogivri, Ontruzant, and Trazimera and instead of Herceptin (trastuzumab)

 

Members age 18 years and older who have not received the above drugs in the last 12 months, must be redirected to the biosimilar.  CalPERS has final authority over benefit changes for their PPO Plans and has elected to make a change in their benefit plan.

 

What is a Biosimilar?

  • A biosimilar is a biological product
    • FDA‐approved biosimilars have been compared to an FDA‐approved biologic, known as the reference product.
  • A biosimilar is highly similar to a reference product
    • For approval, the structure and function of an approved biosimilar were compared to a reference
  • A biosimilar has no clinically meaningful differences in safety, purity, or potency compared to the reference product
  • A biosimilar is approved by the FDA after rigorous evaluation and testing by the
    • Because biosimilars meet the FDA’s standards for approval, are manufactured in FDA‐licensed facilities, and are tracked as part of post‐market surveillance to ensure continued safety; Prescribers and patients should have no concerns about using these medications instead of reference

 

Effective January 1, 2022, the changes listed in the table below apply to CalPERS PERS Platinum and PERS Gold basic PPO adult members.

Effective for basic PERS Platinum and PERS Gold PPO members on January 1, 2022

Therapeutic Class

Medication

Benefit Change

Antineoplastic and Selective Vascular Endothelial Growth Factor (VEGF) Antagonist Agents

EXCLUDES Ophthalmologic indications

Bevacizumab (Avastin)

Members age 18 years and older who have not received bevacizumab (Avastin) therapies in the last 12 months must be directed to the biosimilars Mvasi, Zirabev

Erythropoiesis Stimulating Agents

Epoetin alfa (Epogen and Procrit)

Members age 18 years and older who have not received epoetin alfa (Epogen and Procrit) therapies in the last 12 months must be directed to the biosimilars Retacrit

Colony Stimulating Factor Agents

Filgrastim (Neupogen)

Members age 18 years and older who have not received filgrastim (Neupogen) therapies in the last 12 months must be directed to the biosimilars Nivestym, Zarxio

Colony Stimulating Factor Agents

Pegfilgrastim (Neulasta)

Members age 18 years and older who have not received pegfilgrastim (Neulasta) therapies in the last 12 months must be directed to the biosimilars Fulphila, Nyvepria, Udenyca, Ziextenzo

Antineoplastic and Monoclonal Antibody Agents

 

Rituximab (Rituxan)

Members age 18 years and older who have not received rituximab (Rituxan) therapies in the last 12 months must be directed to the biosimilars Riabni, Ruxience, Truxima

 

Antineoplastic Agent

Trastuzumab (Herceptin)

Members age 18 years and older who have not received trastuzumab (Herceptin) therapies in the last 12 months must be directed to the biosimilars Herzuma, Kanjinti, Ogivri, Ontruzant, Trazimera


What action do I need to take?

Direct eligible CalPERS PERS Platinum and PERS Gold PPO basic members needing this specific therapy to approved biosimilar agents including but not limited to the following:

  • Mvasi, Zirabev
  • Retacrit
  • Nivestym, Zarxio
  • Fulphila, Nyvepria, Udenyca, Ziextenzo
  • Riabni, Ruxience, Truxima
  • Herzuma, Kanjinti, Ogivri, Ontruzant, and Trazimera

 

To ensure care is delivered timely, please initiate all prior authorization requests, as appropriate, for CalPERS PERS Platinum and PERS Gold PPO basic members for the approved biosimilar therapy as described above.

 

What if I need assistance?

Call our dedicated Anthem Blue Cross CalPERS Customer Service Department at 1‐877‐737‐7776 if your patient cannot use an approved biosimilar therapy as described above. We recognize the unique aspects of patients’ cases.


723-0322-PN-CA

Federal Employee Program (FEP)CommercialMarch 1, 2022

HEDIS 2022 Federal Employee Program® medical record request requirements

Reveleer is the contracted vendor to gather member medical records on behalf of the Blue Cross and Blue Shield Federal Employee Program. We value the relationship with our providers and ask that you respond to the detailed requests in support of risk adjustment, HEDIS and other government required activities within the requested timeframe.

 

Reveleer will work with you to obtain records via fax, mail, remote electronic medical record (EMR) access, or onsite scanning/EMR download (as necessary).  We ask that you comply promptly within five (5) business days of the record requests.

 

If you have any questions, you can reach a Reveleer representative by calling 855-454-6182 or contact Ify Ifezulike with Blue Cross Blue Shield Federal Employee Program at 419-494-6954.

 

HEDIS® is a registered trademark of the National Committee for Quality Assurance (NCQA).
735-0322-PN-CA

Federal Employee Program (FEP)CommercialMarch 1, 2022

Change to the Federal Employee Program® Clinical Grievance and Appeal address

The Anthem Blue Cross (Anthem) Federal Employee Program is making an address change for the clinical grievance and appeal submissions to help accommodate recent office environment and staffing changes.

 

The new address is effective immediately and should be used for all clinical grievance and appeal submissions, including new requests and medical records for existing requests.

 

Old Address:                                                      New Address:

Anthem – FEP Appeals                                       Anthem – FEP Appeals

3075 Vandercar Way                                          PO Box 105318

Cincinnati OH 45209                                          Atlanta, GA 30348

 

The fax number for clinical appeals for the Anthem Federal Employee Program remains the same at 855-207-9935. If you have any questions, please contact FEP customer service at 800-284-9093.


569-0322-PN-CA

State & FederalMedicaidMarch 1, 2022

It is CAHPs survey time!

Consumer Assessment of Healthcare Providers and Systems (CAHPS®) is an annual standardized survey conducted between February and May to assess consumers’ experience with their providers and health plan. A random sample of your adult or child patients may receive the survey.

 

More than half of the questions used for scoring are directly impacted by providers. These questions are:

  • When you needed care right way, how often did you get care as soon as you needed?
  • How often did you get an appointment for a check-up or routine care as soon as you needed?
  • How often was it easy to get the care, tests, or treatment you needed?
  • How often did you get an appointment to see a specialist as soon as you needed?
  • How often did your personal doctor seem informed and up-to-date about the care you got from other doctors or other health providers?
  • How would you rate your personal doctor?
  • How would you rate the specialist you see most often?
  • How would you rate all your healthcare in the last six months?

 

Interested in how you can improve CAHPS performance?

Anthem Blue Cross offers an online course for providers and office staff designed to learn how to improve communication skills, build patient trust and commitment, and expand your knowledge of the CAHPS survey. The Improving the Patient Experience course is available at no cost and is eligible for one continuing medical education (CME) credit by the American Academy of Family Physicians. It can be accessed at: https://www.mydiversepatients.com/le-ptexp.html.



ACA-NU-0403-21

State & FederalMedicare AdvantageMarch 1, 2022

Keep up with Medicare news – March 2022

Please continue to check for important Medicare Advantage updates at https://www.anthem.com/ca/provider/medicare-advantage/ for the latest Medicare Advantage information, including:

 

State & FederalMedicare AdvantageMarch 1, 2022

New Strategic Provider System will launch in April 2022

In April 2022, Anthem Blue Cross (Anthem) will replace its current internal provider demographic management system with a new Strategic Provider System (SPS). This investment in advanced technology will significantly improve provider data accuracy and transparency, enhancing the overall provider experience. New system features will strengthen our ability to match submitted claims for more accurate pricing and processing.

 

System upgrades special notice

During the first phase of our improvements, Anthem will implement system upgrades April 1, 2022, through April 8, 2022. Provider updates submitted during this period will be processed after April 8, 2022. We appreciate your patience as we upgrade our systems.

 

Next steps: new Provider Data Management coming soon

Beginning in June 2022, the second phase of our improvement initiative will be integration with Availity’s* Provider Data Management (PDM) functionality, which will roll out in phases. This single, easy-to-use portal, will allow providers to view, maintain, update, and attest to the accuracy of provider demographic information for Anthem. The Availity portal will enable providers to complete required verifications online via a simplified quick verification procedure – eliminating the need to fax, email, or use separate online forms. This service will replace the way you currently send Anthem your demographic updates.

 

Get ready for the change today

If your organization is not already registered on the Availity Portal, we strongly encourage you to get started right away. Your organization’s designated administrator can go to https://www.availity.com to register and find other helpful information about using Availity. Availity is Anthem’s secure provider portal platform where providers can enjoy the convenience of digital transactions, including prior authorization submissions, claims submission and benefit and eligibility look-up.

 

For questions about Availity, call 800-AVAILITY (800-282-4548).

 

* Availity, LLC is an independent company providing administrative support services on behalf of Anthem Blue Cross.
ABCCRNU-0223-22 and ABCCARE-0631-21

State & FederalMedicare AdvantageMarch 1, 2022

Provider notification for utilization management authorization rule operations workgroup item 2662

On June 1, 2022, prior authorization (PA) requirements will change for a code covered by Anthem Blue Cross. Federal and state law, as well as state contract language and CMS guidelines, including definitions and specific contract provisions/exclusions take precedence over these precertification rules and must be considered first when determining coverage. Noncompliance with new requirements may result in denied claims.

 

Prior authorization requirements will be added for the following codes:

  • K1022 — Addition to lower extremity prosthesis, endoskeletal, knee disarticulation, above knee, hip disarticulation, positional rotation unit, any type

 

Not all PA requirements are listed here. PA requirements are available to contracted providers on the provider website at https://www.anthem.com/ca/medicareprovider > Login or by accessing Availity.* Once logged in to Availity at http://availity.com, select Patient Registration > Authorizations & Referrals, then choose Authorizations or Auth/Referral Inquiry, as appropriate. Contracted and noncontracted providers who are unable to access Availity may call the number on the back of the member’s ID card.

 

* Availity, LLC is an independent company providing administrative support services on behalf of Anthem Blue Cross.


ABCCRNU-0222-22

State & FederalMedicare AdvantageMarch 1, 2022

Teamsters Retiree Trust offers Medicare Advantage option

Effective January 1, 2022, Teamsters Retiree Trust will offer a Medicare Preferred PPO plan with Anthem Blue Cross. Retirees with Medicare Parts A and B are eligible to enroll in the Local Preferred Provider Organization (LPPO) product.

 

Benefits

The plan includes the National Access Plus benefit, which allows retirees to receive services from any provider, as long as the provider is eligible to receive payments from Medicare. The Medicare Advantage plan offers the same hospital and medical benefits that original Medicare covers, while covering additional benefits that original Medicare does not, such as LiveHealth Online* (telehealth) and SilverSneakers®.*

 

Teamsters Retiree Trust members’ copay or coinsurance percentage will be the same whether their provider is in- or out-of-network. Locally or nationwide, doctors or hospitals, member share-of-cost (SOC) doesn’t change.

 

The prefix on Teamsters Retiree Trust member ID cards will be MBL. The cards will also show the Teamsters Retiree Trust name and MA and PPO icons.

 

Claims

Providers will follow their normal claim filing procedures for Teamsters Retiree Trust member claims. Claims should not be filed with original Medicare. Contracted and noncontracted providers may call Provider Services at 833-848-8730, the number on the back of the member’s ID card, for eligibility, prior authorization requirements, and any questions about the Teamsters Retiree Trust member benefits or coverage.

 

Detailed prior authorization requirements also are available to contracted providers by accessing the Provider Self-Service Tool at https://www.availity.com.*

 

* LiveHealth Online is the trade name of Health Management Corporation, an independent company, providing telehealth services on behalf of Anthem Blue Cross. Tivity Health, Inc. is an independent company providing the SilverSneakers fitness program on behalf of Anthem Blue Cross. Availity, LLC is an independent company providing administrative support services on behalf of Anthem Blue Cross.

ABCCRNU-0220-21

 

State & FederalMedicare AdvantageMarch 1, 2022

Clinical criteria updates

Summary: On September 22, 2021, and November 19, 2021, the Pharmacy and Therapeutics (P&T) committee approved the following Clinical Criteria applicable to the medical drug benefit for Anthem Blue Cross. These policies were developed, revised, or reviewed to support clinical coding edits.

 

Visit Clinical Criteria to search for specific policies. If you have questions or need additional information, use this email.

 

See the explanation/definition for each category of Clinical Criteria below:

  • New: newly published criteria
  • Revised: addition or removal of medical necessity requirements, new document number
  • Updates marked with an asterisk (*) notate that the criteria may be perceived as more restrictive

 

Share this notice with other members of your practice and office staff.

 

Please note: The Clinical Criteria listed below applies only to the medical drug benefits contained within the member’s medical policy. This does not apply to pharmacy services.


Effective date

Document number

Clinical Criteria title

New or revised

March 9, 2022

*ING-CC-0204

Tivdak (tisotumab vedotin-tftv)

New

March 9, 2022

*ING-CC-0018

Lumizyme (alglucosidase alfa); Nexviazyme (avalglucosidase alfa-ngpf)

Revised

March 9, 2022

*ING-CC-0128

Tecentriq (atezolizumab)

Revised

March 9, 2022

*ING-CC-0012

Brineura (cerliponase alfa)

Revised

March 9, 2022

*ING-CC-0021

Fabrazyme (agalsidase beta)

Revised

March 9, 2022

*ING-CC-0017

Xiaflex (collagenase clostridium histolyticum)

Revised

March 9, 2022

*ING-CC-0026

Testosterone Injectable

Revised

March 9, 2022

*ING-CC-0100

Istodax (romidepsin)

Revised

March 9, 2022

*ING-CC-0125

Opdivo (nivolumab)

Revised

March 9, 2022

ING-CC-0197

Jemperli (dostarlimab-gxly)

Revised

March 9, 2022

ING-CC-0124

Keytruda (pembrolizumab)

Revised

March 9, 2022

*ING-CC-0061

GnRH Analogs for the Treatment of Non-Oncologic Indications

Revised

March 9, 2022

*ING-CC-0148

Agents for Hemophilia B

Revised

March 9, 2022

*ING-CC-0149

Select Clotting Agents for Bleeding Disorders

Revised

March 9, 2022

*ING-CC-0065

Agents for Hemophilia A and von Willebrand Disease

Revised

March 9, 2022

ING-CC-0168

Tecartus (brexucabtagene autoleucel)

Revised

March 9, 2022

*ING-CC-0195

Abecma (idecabtagene vicleucel)

Revised

March 9, 2022

*ING-CC-0001

Erythropoiesis Stimulating Agents

Revised

March 9, 2022

*ING-CC-0173

Enspryng (satralizumab-mwge)

Revised

March 9, 2022

*ING-CC-0170

Uplizna (inebilizumab-cdon)

Revised

March 9, 2022

*ING-CC-0041

Complement Inhibitors

Revised

March 9, 2022

*ING-CC-0071

Entyvio (vedolizumab)

Revised

March 9, 2022

*ING-CC-0064

Interleukin-1 Inhibitors

Revised

March 9, 2022

*ING-CC-0042

Monoclonal Antibodies to Interleukin-17

Revised

March 9, 2022

*ING-CC-0066

Monoclonal Antibodies to Interleukin-6

Revised

March 9, 2022

*ING-CC-0050

Monoclonal Antibodies to Interleukin-23

Revised

March 9, 2022

*ING-CC-0078

Orencia (abatacept)

Revised

March 9, 2022

*ING-CC-0063

Stelara (ustekinumab)

Revised

March 9, 2022

*ING-CC-0062

Tumor Necrosis Factor Antagonists

Revised

March 9, 2022

ING-CC-0003

Immunoglobulins

Revised

March 9, 2022

*ING-CC-0049

Radicava (edaravone)

Revised

March 9, 2022

*ING-CC-0075

Rituximab Agents for Non-Oncologic Indications

Revised

March 9, 2022

*ING-CC-0072

Selective Vascular Endothelial Growth Factor (VEGF) Antagonists

Revised

March 9, 2022

ING-CC-0107

Bevacizumab for Non-Ophthalmologic Indications

Revised

March 9, 2022

ING-CC-0106

Erbitux (cetuximab)

Revised

March 9, 2022

ING-CC-0105

Vectibix (panitumumab)

Revised

March 9, 2022

ING-CC-0043

Monoclonal Antibodies to Interleukin-5

Revised

March 9, 2022

*ING-CC-0068

Growth Hormone

Revised


ABCCRNU-0219-22

State & FederalMedicare AdvantageMarch 1, 2022

Pharmacy updates

Medication adherence improves overall member health and reduces hospitalizations. According to the World Health Organization, “Increasing the effectiveness of adherence interventions may have a far greater impact on the health of the population than any improvement in specific medical treatments.1

 

Did you know?

  • Most medication-related ER visits and hospitalizations in the U.S. (up to 70%) are caused by

nonadherence to medication.2

  • Studies show that 50 to 60% of patients are not taking their prescribed medications correctly or at all.3
  • Improved adherence can drive positive health and economic outcomes.
  • Patients’ adherence to statin medications at 12 months had improved LDL, reduced hospitalizations, and lower healthcare costs.4

 

Best practices for improving adherence

Support the implementation of medication nonadherence prevention strategies at each step of the medication use process:

  • Prescribe maintenance medications for diabetes, cholesterol, and hypertension from the

Anthem Blue Cross (Anthem) Medicare Advantage $0 copay list.

 

  • Encourage IngenioRx* Home Delivery to improve medication adherence, prevent refill gaps, avoid long waits at the pharmacy, and to reduce costs.
    • IngenioRx Home Delivery members have 2 to 3% higher adherence rates
    • E-prescribe, fax 800-378-0323, or phone-in prescriptions 833-203-1742

 

  • Enrolled nonadherent patients may benefit from a multi-dose packaging of medications.

CVS pharmacy® SimpleDose™ and PillPack are preferred pharmacies that offer multi-dose packaging with free home delivery. To enroll, go to:

    • CVS.com/multidose or call 800-753-0596. Members may also enroll at their local CVS pharmacy. Members residing in the District of Columbia, Georgia, or South Carolina should call 844-650-1637.
    • Pillpack.com/blue or call 866-282-9462.

 

  • Offer members the opportunity to use ZipDrug, which offers free access to high performing pharmacies that provide customized medication services, hand-delivered prescriptions, and increase medication adherence rates. Go to anthem.com/zipdrug or call 844-947-3748.
    • Patients who take medications for diabetes, cholesterol, and hypertension and enrolled in ZipDrug had a 4 to 10% increase in medication adherence rates.

 

  • Encourage digital solutions: Sydney app can help Anthem members manage their medications through:
    • Enrollment in ZipDrug
    • Home delivery set-up
    • Manage auto-refill and renew
    • Text message reminders on prescriptions

 

Want more information regarding all the recommended best practices?

Best practices for medication adherence are reviewed in this brief video.

 

Resources:

1 World Health Organization. Adherence to long-term therapies: evidence for action. Geneva:

   World Health Organization; 2003. http://apps.who.int/medicinedocs/pdf/s4883e/s4883e.pdf.

   Accessed Dec.22, 2021.

2 Cutler, Rachelle Louise et al. “Economic impact of medication non-adherence by disease groups: systematic

   review.” BMJ open vol. 8,1 e016982. 21 Jan. 2018, doi:10.1136/bmjopen-2017-016982

3 Journal of Managed Care & Specialty Pharmacy 2020 26:12, 1529-1537

4 JAMA.2018;320(23):2461-2473. https://pubmed.ncbi.nlm.nih.gov/30561486/
ABCCRNU-0035-22

 

State & FederalMedicare AdvantageMarch 1, 2022

Annual wellness visits for Medicare Advantage members

Annual wellness visits (AWVs) are an important yet underutilized vehicle for ensuring successful value-based payment (VBP) arrangements. In 2022, there is an opportunity to increase your AWVs and, by extension, the health of your patients and your success in VBPs. 

Per the American Academy of Family Practitioners (AAFP), “90 percent of patients who had received an AWV said they did so at the recommendation of their physician.” AWVs are a yearly exam (usually with a physician) to develop or update a personalized prevention plan and assess health status and any social, psychological, and behavioral health risks. An AWV can be a useful tool for improving quality of care, providing proactive care management, facilitating care coordination, and positively impacting up to 20 Medicare Advantage Star measure ratings for health plans.

There is often confusion between an AWV and an annual routine physical (ARP). The ARP is more comprehensive than an AWV. It consists of a physical exam by a physician and includes bloodwork, screenings, and other tests. The AWV involves checking standard measurements such as blood pressure, height, and weight. AWVs are free for Medicare Advantage members and, in many instances, can be conducted remotely via telehealth.

Note: CMS does allow both visit types to occur on the same date/time and providers can submit one claim encompassing each type.

There are many provider benefits for completing an AWV, including:

  • Opportunity to develop a complete medical history for members
  • Strengthened relationship with member
  • Ability to provide proactive care to member
  • Increased performance on quality metrics
  • An ongoing, sustainable revenue stream for practice
  • Vehicle for providers to obtain caregiver demographics

 

There are also many member benefits for completing an AWV, including:

  • No copay
  • Strengthened relationship with healthcare providers
  • Annual comprehensive preventive evaluation
  • Reduced risk of chronic conditions
  • Keeps members out of the hospital
  • Prevents accidents at home

 

In the ever-increasing emphasis on value-based care that focuses on shared savings, it is urgent for providers to complete an AWV for each of their assigned members. Doing so keeps members healthy, reduces healthcare costs, and can increase practice revenues.


ABCCARE-0724-22

State & FederalMedicaidMarch 1, 2022

Keep up with Medi-Cal news – March 2022

State & FederalMedicaidMarch 1, 2022

Urinary tract infection toolkits are on the way

To support the health of our members, Anthem Blue Cross (Anthem) is sending urinary tract infection (UTI) toolkits to select members who were seen in the ER for a UTI.

 

This useful kit contains:

  • A water bottle to help your patient stay
  • UTI test strips with instructions on use if having These are test strips that are also available over the counter.
  • Basic instructions on how to use the toolkit and reasons to seek

 

Anthem members may reach out to you when they receive their toolkit.  If you have any questions, please contact one of our Medi-Cal Customer Care Centers at:

  • 800-407-4627 (outside A. County)
  • 888-285-7801 (inside A. County)

ACA-NU-0414-22 and ACA-NU-0381-21

State & FederalMedicaidMarch 1, 2022

Clinical utilization management guidelines update

The Clinical Utilization Management (UM) Guidelines and Third-Party Criteria below were developed and/or revised to support clinical coding edits. Note, several policies and guidelines were revised to provide clarification only and are not included. Existing precertification requirements have not changed.

 

Please share this notice with other members of your practice and office staff. To view a guideline,  visit https://www.anthe m.com/ca/provide r/policie s/clinical-guide line s/search.

 

Updates:

Updates marked with an asterisk (*) notate that the criteria may be perceived as more restrictive.

  • *CG-LAB-14 — Respiratory Viral Pane l Testing in the Outpatie nt Se tting
    • Clarified that respiratory viral panel (RVP) testing in the outpatient setting is medically necessary when using limited panels involving five targets or less when criteria are met
    • Added RVP testing in the outpatient setting using large panels involving six or more targets as not medically necessary
    • Added RVP testing in the outpatient setting using large panels involving six or more targets as not medically necessary



ACA-NU-0410-22 and ACA-NU-0393-21